Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Endpoints
Thu, 11/3/22 - 12:00 pm
Tricida
chronic kidney disease
M&A
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Johnson & Johnson to Buy Abiomed for $16.6B
Medical Devices and Diagnostics Industry
Tue, 11/1/22 - 11:08 am
JNJ
devices
Medtech
Abiomed
M&A
Thermo Fisher Scientific buys European diagnostics firm for $2.6B
Medical Marketing and Media
Mon, 10/31/22 - 10:45 am
Thermo Fisher Scientific
M&A
The Binding Site Group
Europe
diagnostics
Sanofi reveals setback for cancer drug acquired in Synthorx buyout
BioPharma Dive
Fri, 10/28/22 - 10:56 am
Sanofi
Synthorx
M&A
SAR444245
cancer
Bone Fixes Fracture with "Synergistic" Reverse Merger, Becomes BioSenic
BioSpace
Fri, 10/28/22 - 10:36 am
Bone Therapeutics
cell therapy
M&A
reverse merger
Medsenic
BioSenic
Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'
Endpoints
Fri, 10/28/22 - 10:22 am
Merck
Rob Davis
Pharma CEOs
M&A
Sumitomo nets Myovant in $2.9B buyout, adding IVF asset to pipeline
Fierce Biotech
Mon, 10/24/22 - 11:20 pm
Sumitomo Pharma
M&A
Myovant
IVF
In Vitro Fertilization
Orgovyx
Myfembree
AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy
BioSpace
Thu, 10/20/22 - 11:29 pm
AbbVie
M&A
DJS Antibodies
pulmonary fibrosis
antibodies
Where Will Biogen Be in 5 Years?
Motley Fool
Thu, 10/20/22 - 10:39 am
Biogen
Aduhelm
lecanemab
Alzheimer's disease
M&A
Love Pharma moves to buy transdermal opioid-use disorder player
Fierce Pharma
Wed, 10/19/22 - 10:41 am
Love Pharma
opioid-use disorder
Naltrexone Therapeutics
M&A
alcohol-use disorder
Editas Rumored to be in “Advanced Discussions” around Potential Sale of Oncology Assets
BioSpace
Tue, 10/18/22 - 10:13 pm
Editas Medicine
gene editing
CRISPR
M&A
oncology
J&J holds off on volatile M&A market but has plenty of cash for a deal
Endpoints
Tue, 10/18/22 - 10:02 pm
JNJ
M&A
Korean firm LG Chem buying AVEO Oncology for $566M
CP WIre
Tue, 10/18/22 - 01:57 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Korean firm LG Chem buying AVEO Oncology for $566M
Tue, 10/18/22 - 01:55 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Eli Lilly to buy precision medicine company Akouos for $487M
Medical Marketing and Media
Tue, 10/18/22 - 11:14 am
Eli Lilly
Akouos
M&A
hearing loss
precision medicine
Nektar and PureTech merger talks called off
Pharmaforum
Tue, 10/11/22 - 10:40 am
M&A
Nektar Therapeutics
PureTech
Beckman Coulter Dips into AI with New Acquisition
Medical Devices and Diagnostics Industry
Tue, 10/11/22 - 10:06 am
Beckman Coulter
M&A
artificial intelligence
StoCastic
Medtech
Nektar and Puretech make strange bedfellows
EP Vantage
Fri, 10/7/22 - 10:42 am
Nektar Therapeutics
PureTech Health
M&A
Merck KGaA says it'll consider 'larger-scale' acquisitions from 2023 onward
Fierce Pharma
Thu, 10/6/22 - 07:08 pm
Merck
KGaA
M&A
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »